Langenbeck's Archives of Surgery

, Volume 399, Issue 3, pp 333–341 | Cite as

Predictors of mortality for necrotizing soft-tissue infections: a retrospective analysis of 64 cases

Original Article

Abstract

Purpose

Necrotizing soft-tissue infection (NSTI) is a rare, but rapidly progressive and life-threatening disease with a high morbidity and mortality. The aim of the present study was to evaluate predictors of mortality in a group of patients with NSTIs treated at a single center.

Methods

The medical records of all patients that were treated because of a NSTI at our department between 1996 and 2011 were retrospectively analyzed. To identify factors that were associated with patients’ outcome variables including demographic, clinical, laboratory, and microbiologic parameters were compared between the group of survivors and non-survivors.

Results

Sixty-four patients with the diagnosis of a NSTI were identified. The overall mortality was 32.8 %. Multiple regression analyses identified the development of a renal failure during the hospital stay and more importantly, the presence of visible skin necrosis on the initial clinical examination as independent prognostic markers for NSTIs.

Conclusion

In patients with NSTIs, skin necrosis may serve as an indicator for an advanced stage of the disease. Thus, the presence of visible skin necrosis as an independent predictor of mortality emphasizes the outstanding importance of early diagnosis and prompt treatment to improve the prognosis of patients with NSTIs.

Keywords

Necrotizing soft-tissue infections NSTI Skin necrosis Surgical debridement 

Notes

Conflicts of interest

None.

References

  1. 1.
    Jones J (1871) Surgical memoirs of the war of the rebellion: investigation upon the nature, causes, and treatment of hospital gangrene as prevailed in the confederate armies 1861-1865. US Sanitary Commission, New YorkGoogle Scholar
  2. 2.
    Elliott DC, Kufera JA, Myers RA (1996) Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 224:672–683Google Scholar
  3. 3.
    McHenry CR, Piotrowski JJ, Petrinic D et al (1995) Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 221:558–563, discussion 563-555PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Green RJ, Dafoe DC, Raffin TA (1996) Necrotizing fasciitis. Chest 110:219–229PubMedCrossRefGoogle Scholar
  5. 5.
    Krieg A, Rohrborn A, Schulte Am Esch J et al (2009) Necrotizing fasciitis: microbiological characteristics and predictors of postoperative outcome. Eur J Med Res 14:30–36PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Singh G, Sinha SK, Adhikary S et al (2002) Necrotising infections of soft tissues—a clinical profile. Eur J Surg 168:366–371Google Scholar
  7. 7.
    Shimizu T, Tokuda Y (2010) Necrotizing fasciitis. Intern Med 49:1051–1057Google Scholar
  8. 8.
    Puvanendran R, Huey JC, Pasupathy S (2009) Necrotizing fasciitis. Can Fam Physician 55:981–987PubMedCentralPubMedGoogle Scholar
  9. 9.
    Chen JL, Fullerton KE, Flynn NM (2001) Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 33:6–15Google Scholar
  10. 10.
    Morgan MS (2010) Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect 75:249–257Google Scholar
  11. 11.
    Anaya DA, Bulger EM, Kwon YS et al (2009) Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt) 10:517–522Google Scholar
  12. 12.
    Huang KF, Hung MH, Lin YS et al (2011) Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma 71:467–473; discussion 473Google Scholar
  13. 13.
    Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212Google Scholar
  14. 14.
    Efron B (2013) Estimation and accuracy after model selection. J Am Stat Assoc. doi:10.1080/01621459.2013.823775 Google Scholar
  15. 15.
    Ryssel H, Germann G, Kloeters O et al (2010) Necrotizing fasciitis of the extremities: 34 cases at a single centre over the past 5 years. Arch Orthop Trauma Surg 130:1515–1522Google Scholar
  16. 16.
    Eke N (2000) Fournier’s gangrene: a review of 1726 cases. Br J Surg 87:718–728PubMedCrossRefGoogle Scholar
  17. 17.
    Golger A, Ching S, Goldsmith C et al (2007) Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 119:1803–1807PubMedCrossRefGoogle Scholar
  18. 18.
    Boyer A, Vargas F, Coste F et al (2009) Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 35:847–853PubMedCrossRefGoogle Scholar
  19. 19.
    Heitmann C, Pelzer M, Bickert B et al (2001) Surgical concepts and results in necrotizing fasciitis. Chirurg 72:168–173PubMedCrossRefGoogle Scholar
  20. 20.
    Martinschek A, Evers B, Lampl L et al (2012) Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int 89:173–179Google Scholar
  21. 21.
    Tsitsilonis S, Druschel C, Wichlas F et al (2013) Necrotizing fasciitis: is the bacterial spectrum changing? Langenbecks Arch Surg 398:153–159Google Scholar
  22. 22.
    Anaya DA, Mcmahon K, Nathens AB et al (2005) Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 140:151–157, discussion 158PubMedCrossRefGoogle Scholar
  23. 23.
    Yanar H, Taviloglu K, Ertekin C et al (2006) Fournier’s gangrene: risk factors and strategies for management. World J Surg 30:1750–1754PubMedCrossRefGoogle Scholar
  24. 24.
    Hong YC, Chou MH, Liu EH et al (2009) The effect of prolonged ED stay on outcome in patients with necrotizing fasciitis. Am J Emerg Med 27:385–390PubMedCrossRefGoogle Scholar
  25. 25.
    Bair MJ, Chi H, Wang WS et al (2009) Necrotizing fasciitis in southeast Taiwan: clinical features, microbiology, and prognosis. Int J Infect Dis 13:255–260PubMedCrossRefGoogle Scholar
  26. 26.
    Bakleh M, Wold LE, Mandrekar JN et al (2005) Correlation of histopathologic findings with clinical outcome in necrotizing fasciitis. Clin Infect Dis 40:410–414PubMedCrossRefGoogle Scholar
  27. 27.
    Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655PubMedCrossRefGoogle Scholar
  28. 28.
    Wong CH, Chang HC, Pasupathy S et al (2003) Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 85-A:1454–1460PubMedGoogle Scholar
  29. 29.
    Lee TC, Carrick MM, Scott BG et al (2007) Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg 194:809–812, discussion 812-803PubMedCrossRefGoogle Scholar
  30. 30.
    Sarani B, Strong M, Pascual J et al (2009) Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 208:279–288PubMedCrossRefGoogle Scholar
  31. 31.
    Wang YS, Wong CH, Tay YK (2007) Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol 46:1036–1041PubMedCrossRefGoogle Scholar
  32. 32.
    Frazee BW, Fee C, Lynn J et al (2008) Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med 34:139–146PubMedCrossRefGoogle Scholar
  33. 33.
    Wall DB, Klein SR, Black S et al (2000) A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg 191:227–231PubMedCrossRefGoogle Scholar
  34. 34.
    Callahan TE, Schecter WP, Horn JK (1998) Necrotizing soft tissue infection masquerading as cutaneous abcess following illicit drug injection. Arch Surg 133:812–817, discussion 817-819PubMedCrossRefGoogle Scholar
  35. 35.
    Kobayashi L, Konstantinidis A, Shackelford S et al (2011) Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma 71:1400–1405Google Scholar
  36. 36.
    Hassan Z, Mullins RF, Friedman BC et al (2010) Treating necrotizing fasciitis with or without hyperbaric oxygen therapy. Undersea Hyperb Med 37:115–123Google Scholar
  37. 37.
    George ME, Rueth NM, Skarda DE et al (2009) Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt) 10:21–28Google Scholar
  38. 38.
    Wilkinson D, Doolette D (2004) Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg 139:1339–1345PubMedCrossRefGoogle Scholar
  39. 39.
    Brown DR, Davis NL, Lepawsky M et al (1994) A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 167:485–489Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Surgery (A)Heinrich-Heine-University and University Hospital DüsseldorfDüsseldorfGermany
  2. 2.Coordination Center for Clinical TrialsHeinrich-Heine-University and University Hospital DüsseldorfDüsseldorfGermany

Personalised recommendations